False negative screening tests for lupus anticoagulants -An unrecognized problem?

Thrombosis Research

Volumn 82, Issue 5, 1996, Pages 445-451

  Jacobsen, Eva Marie ^a   Wisløff, Finn ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antiphospholipid antibodies; Diluted activated partial thromboplastin time; Kaolin clotting time; Lupus anticoagulant

Indexed keywords

LUPUS ANTICOAGULANT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCREENING TEST; THROMBOSIS;

ADULT; AGED; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME;

EID: 0029936253     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00094-1     Document Type: Article

References (22)

1. TRIPLETT, D.A. New diagnostic strategies for lupus anticoagulants and antiphospholipid antibodies. Haemostasis 24, 155-164, 1994.
2. TRIPLETT, D.A. Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res 78, 1-31, 1995.
3. VERMYLEN, J. and ARNOUT, J. Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes? J Lab Clin Med 120, 10-12, 1992.
4. OOSTING, J.D., DERKSEN, R.H.W.M., BOBBINK, I.W.G., HACKENG, T.M., BOUMA, B.N. and DE GROOT, P.G. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 81, 2618-2625, 1993.
5. KHAMASHTA, M.A., HARRIS, E.N., GHARAVI, A.E., DERUE, G., GIL, A., VÁZQUEZ, J.J. and HUGHES, G.R.V. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 47, 849-854, 1988.
6. CARRERAS, L.O., VERMYLEN, J., SPITZ, B. and VAN ASSCHE, A. "Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 88, 890-894, 1981.
7. ÅRFORS, L., VESTERQVIST, O., JOHNSSON, H. and GREEN, K. Increased tromboxane formation in patients with antiphospholipid syndrome. Eur J Clin Invest 20, 607-612, 1990.
8. SANFELIPPO, M.J. and DRAYNA, C.J. Prekallikrein inhibition associated with the lupus anticoagulant. Am J Clin Pathol 77, 275-279, 1982.
9. EXNER, T., TRIPLETT, D.A., TABERNER, D. and MACHIN, S.J. Scientific and standardization committee communications. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the standardization of lupus anticoagulants. Thromb Haemost 65, 320-322, 1991.
10. SCHJETLEIN, R., SLETNES, K.E. and WISLØFF F. A quantitative, semi-automated and computer-assisted test for lupus anticoagulant. Thromb Res 69, 239-250, 1993.
11. BRANDT, J.T., TRIPLETT, D.A., ALVING, B. and SCHARRER, I. Scientific and standardization committee communications. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on lupus anticoagulant/antiphospholipid antibody of the Scientific and Standardization committee of the ISTH. Thromb Haemost 74, 1185-90, 1995.
12. MACHIN, S.J., GIDDINGS, J.C., GREAVES, M., HUTTON, R.A, MACKIE, I.J., MALIA, R.G. and TABERNER, D.A. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol 44, 885-889, 1991.
13. ALVING, B.M., BALDWIN, P.E., RICHARDS, R.L. and JACKSON, B.J. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants. Thromb Haemost 54, 709-712, 1985.
14. EXNER, T., RICKARD, K.A. and KRONENBERG, H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 40, 143-151, 1978.
15. THIAGARAJAN, P., PENGO, V. and SHAPIRO, S.S. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 68, 869-874.
16. SCHLEIDER, M.A., NACHMAN, R.L., JAFFE, E.A. and COLEMAN, M. A clinical study of the lupus anticoagulant. Blood 48, 499-509, 1976.
17. BRANDT, J.T., TRIPLETT, D.A., MUSGRAVE, K. and ORR, C. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants. Arch Pathol Lab Med 111, 120-124, 1987.
18. LO, S.C.L., OLDMEADOW, M.J., HOWARD, M.A. and FIRKIN, B.G. Comparison of laboratory tests used for identification of the lupus anticoagulant. Am J Hematol 30, 213-220, 1989.
19. WISLØFF, F., SLETNES, K.E. and MICHAELSEN, T. Shared idiotypic determinant in monoand polyclonal antiphospholipid antibodies with lupus anticoagulant activity. Thromb Res 61, 201-211, 1991.
20. LESPERANCE, B., DAVID, M., RAUCH, J., INFANTE-RIVARD, C. and RIVARD, G.E. Relative sensitivity of different tests in the detection of low titer lupus anticoagulants. Thromb Haemost 60, 217-219, 1988.
21. EXNER, T., TRIPLETT, D.A., TABERNER, D.A., HOWARD, M.A. and HARRIS, E.N. Scientific and standardization committee communications. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-I). Thromb Haemost 64, 478-484, 1990.
22. SMIRNOV, M.D., TRIPLETT, D.T., COMP, P.C., ESMON, N.L. and ESMON, C.T. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest 95, 309-316, 1995.